42.10
0.59%
-0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CERE Giù?
Forum
Previsione
Cerevel Therapeutics Holdings Inc Azioni (CERE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | -3.668 |
Operating Expenses
|
25.39%
139.56
|
111.31 | 96.84 | 99.55 | 107.25 |
Interest Income/Expense |
0.11%
2.647
|
2.644 | 2.64 | 2.636 | 2.632 |
Operating Income/Loss |
25.39%
-139.56
|
-111.31 | -96.84 | -99.55 | -107.25 |
Income/Loss From Continuing Operations Before Tax |
37.65%
-132.47
|
-96.24 | -99.43 | -104.20 | -92.65 |
Income Tax Expense/Benefit |
52.85%
0.188
|
0.123 | 0.107 | 0.085 | - |
Income/Loss From Continuing Operations After Tax |
37.67%
-132.66
|
-96.36 | -99.53 | -104.29 | -92.81 |
Net Income/Loss
|
37.67%
-132.66
|
-96.36 | -99.53 | -104.29 | -92.81 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
96.83%
4.9873
|
157.50 | 157.05 | 156.65 | 1.7214 |
Diluted Average Shares |
96.83%
4.9873
|
157.50 | 157.05 | 156.65 | 1.7214 |
Basic Earnings Per Share |
24.59%
-0.76
|
-0.61 | -0.63 | -0.67 | -0.59 |
Diluted Earnings Per Share |
24.59%
-0.76
|
-0.61 | -0.63 | -0.67 | -0.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):